These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 33921721)
1. Anti-TNF-α Compounds as a Treatment for Depression. Uzzan S; Azab AN Molecules; 2021 Apr; 26(8):. PubMed ID: 33921721 [TBL] [Abstract][Full Text] [Related]
2. Anti-TNF-alpha therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs. Whitehouse MW Inflammopharmacology; 2004; 12(3):223-7. PubMed ID: 15527546 [TBL] [Abstract][Full Text] [Related]
3. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor. Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749 [TBL] [Abstract][Full Text] [Related]
4. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Soczynska JK; Kennedy SH; Goldstein BI; Lachowski A; Woldeyohannes HO; McIntyre RS Neurotoxicology; 2009 Jul; 30(4):497-521. PubMed ID: 19477018 [TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline for bipolar depression: A pilot study. Rodrigues NB; Toma S; McIntyre RS; Badulescu S; Goldstein BI; MacIntosh BJ; Mansur RB; Rosenblat JD Psychiatry Res; 2024 Nov; 341():116152. PubMed ID: 39226874 [No Abstract] [Full Text] [Related]
6. Peripheral inflammation during abnormal mood states in bipolar I disorder. Fiedorowicz JG; Prossin AR; Johnson CP; Christensen GE; Magnotta VA; Wemmie JA J Affect Disord; 2015 Nov; 187():172-8. PubMed ID: 26339927 [TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide repeated challenge followed by chronic mild stress protocol introduces a combined model of depression in rats: reversibility by imipramine and pentoxifylline. Elgarf AS; Aboul-Fotouh S; Abd-Alkhalek HA; El Tabbal M; Hassan AN; Kassim SK; Hammouda GA; Farrag KA; Abdel-tawab AM Pharmacol Biochem Behav; 2014 Nov; 126():152-62. PubMed ID: 25268312 [TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions. Vilar-Pereira G; Silva AA; Pereira IR; Silva RR; Moreira OC; de Almeida LR; de Souza AS; Rocha MS; Lannes-Vieira J Brain Behav Immun; 2012 Oct; 26(7):1136-49. PubMed ID: 22841695 [TBL] [Abstract][Full Text] [Related]
9. Effects of Dexamethasone and Pentoxifylline on Mania-like and Depression-like Behaviors in Rats. Nassar A; Azab AN Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145284 [TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial. González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012 [TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of pentoxifylline in neonatal rats infected with group B streptococci. Mancuso G; Blandino G; Gambuzza M; Genovese F; Migliardo M; Carbone M; Fera MT; Cusumano V J Chemother; 1995 Oct; 7(5):417-9. PubMed ID: 8596123 [TBL] [Abstract][Full Text] [Related]
12. TNF-alpha as a molecular target in bipolar disorder. Brietzke E; Kapczinski F Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1355-61. PubMed ID: 18316149 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. Netea MG; Blok WL; Kullberg BJ; Bemelmans M; Vogels MT; Buurman WA; van der Meer JW J Infect Dis; 1995 Feb; 171(2):393-9. PubMed ID: 7844376 [TBL] [Abstract][Full Text] [Related]
14. Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice. Queiroz-Junior CM; Bessoni RL; Costa VV; Souza DG; Teixeira MM; Silva TA Life Sci; 2013 Sep; 93(9-11):423-8. PubMed ID: 23911669 [TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid. El Darouti MA; Fakhry Khattab MA; Hegazy RA; Hafez DA; Gawdat HI Eur J Ophthalmol; 2011; 21(5):529-37. PubMed ID: 21279976 [TBL] [Abstract][Full Text] [Related]
17. Triple anti-TNF-alpha therapy in early sepsis: a preliminary report. Schattner A; el-Hador I; Hahn T; Landau Z J Int Med Res; 1997; 25(2):112-6. PubMed ID: 9100167 [TBL] [Abstract][Full Text] [Related]
18. The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases. Schmidt FM; Kirkby KC; Himmerich H Psychiatr Danub; 2014 Sep; 26(3):288-90. PubMed ID: 25191779 [No Abstract] [Full Text] [Related]
19. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Navarro-González JF; Jarque A; Muros M; Mora C; García J Cytokine Growth Factor Rev; 2009 Apr; 20(2):165-73. PubMed ID: 19251467 [TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]